Xigris (drotrecogin alfa (activated)) to be withdrawn due to lack of efficacy

Notice type: 3rd Party Publications

Date: 25/10/2011

Product name or type:
Xigris

Problem Or Issue:
PROWESS-SHOCK study shows no gain in 28-day survival of septic shock patients

Background Information Or Related Documents:
Xigris (drotrecogin alfa (activated)) to be withdrawn due to lack of efficacy Document

Further Information:
European Medicines Agency - Press Release

« Back